<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03234452</url>
  </required_header>
  <id_info>
    <org_study_id>Lactoflorene plus</org_study_id>
    <nct_id>NCT03234452</nct_id>
  </id_info>
  <brief_title>Evaluation of the Beneficial Effects of a Probiotic Product in Healthy Adult Subjects.</brief_title>
  <official_title>Evaluation of the Beneficial Effects of a Probiotic Product (Lactoflorene Plus) in Healthy Adult Subjects in Particular Psychological Stress Conditions.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefarmaco OTC SpA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefarmaco OTC SpA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized, double-blind, placebo-controlled, cross-over trial performed at one centre in
      Italy to explore the ability of a multistrain probiotic mixture, to modulate markers of
      inflammation and intestinal barrier function and gastrointestinal symptoms in healthy
      volunteers with self-reported anxiety.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 23, 2016</start_date>
  <completion_date type="Actual">April 18, 2017</completion_date>
  <primary_completion_date type="Actual">July 21, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>randomized, double-blind, placebo-controlled, cross-over trial performed at one centre</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>double-blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>NK activity</measure>
    <time_frame>45 days</time_frame>
    <description>Verify that Natural Killer activities concentration is significantly higher in the experimental Group compared to the placebo group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IgA, IL8, TNF-Alpha, IL10</measure>
    <time_frame>45 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cortisol, alpha-amylase , chromogranin A</measure>
    <time_frame>45 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>microbiota composition investigation</measure>
    <time_frame>45 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal symptoms (abdominal pain, aerophagia, diarrhea, constipation, diarrhea/constipation alternation )</measure>
    <time_frame>45 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Disbiosis</condition>
  <condition>Abdominal Pain</condition>
  <condition>Constipation</condition>
  <condition>Diarrhea</condition>
  <condition>Stress</condition>
  <arm_group>
    <arm_group_label>Lactoflorene plus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 ml mixture of Lactobacillus acidophilus LA-5®, Bifidobacterium animalis subsp. lactis, BB-12®, Lactobacillus paracasei subsp. paracasei, L. CASEI 431® , Bacillus coagulans BC513, zinc and B-vitamins (niacin, B1, B2, B5, B6, B12 and folic acid) twice a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Lactoflorene plus</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Identical placebo mixture without probiotics, B-vitamins and zinc. The active and placebo products had similar appearance, taste and smell and were provided in identical bottles of 10 ml with identical labelling.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactoflorene plus</intervention_name>
    <description>2 vials with dosing cap (10 mL) a day per os</description>
    <arm_group_label>Lactoflorene plus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo Lactoflorene plus</intervention_name>
    <description>2 vials with dosing cap (10 mL) a day per os</description>
    <arm_group_label>Placebo Lactoflorene plus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Eligible subjects were healthy men and women, 20-35 years old, with a STAI scale, form Y,
        module 1 (state anxiety) score of ≥ 35 and ≥40, for men and women, respectively.

        Exclusion Criteria:

        Most important exclusion criteria were history or diagnosis of GI disease, oral antibiotics
        within 30 days prior to the screening visit, and use of drugs, food or herbal supplements
        for digestive symptoms.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centro Ricerche Cliniche di Verona Srl,</name>
      <address>
        <city>Verona</city>
        <state>(Vr)</state>
        <zip>37100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2017</study_first_submitted>
  <study_first_submitted_qc>July 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2017</study_first_posted>
  <last_update_submitted>July 26, 2017</last_update_submitted>
  <last_update_submitted_qc>July 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lactoflorene plus</keyword>
  <keyword>Bifidobacterium animalis subsp. lactis, BB-12®</keyword>
  <keyword>Lactobacillus acidophilus, LA-5®</keyword>
  <keyword>Lactobacillus paracasei subsp. paracasei, L. CASEI 431®</keyword>
  <keyword>Inflammation</keyword>
  <keyword>gut permeability</keyword>
  <keyword>disbiosis</keyword>
  <keyword>probiotic</keyword>
  <keyword>IgA</keyword>
  <keyword>IL10</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Abdominal Pain</mesh_term>
    <mesh_term>Dysbiosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

